A multiple assay capable of reliably determining vitamins D2 and D3 (ergocalciferol and cholecalciferol), 25(OH)D2 (25-hydroxyvitamin D2) and 25(OH)D3 (25-hydroxyvitamin D3), 24,25(OH)2D (24,25-dihydroxyvitamin D), 25,26(OH)2D (25,26-dihydroxyvitamin D) and 1,25(OH)2D (1,25-dihydroxyvitamin D) in a single 3-5ml sample of human plasma was developed. The procedure involves methanol/methylene chloride extraction of plasma lipids followed by separation ofthe metabolites and purification from interfering contaminants by batch elution chromatography on Sephadex (DeLuca & Schnoes, 1976 
A multiple assay capable of reliably determining vitamins D2 and D3 (ergocalciferol and cholecalciferol), 25(OH)D2 (25-hydroxyvitamin D2) and 25(OH)D3 (25-hydroxyvitamin D3) , 24,25(OH)2D (24,25-dihydroxyvitamin D) , 25,26(OH)2D (25,26-dihydroxyvitamin D) and 1,25(OH)2D (1,25-dihydroxyvitamin D) in a single 3-5ml sample of human plasma was developed. The procedure involves methanol/methylene chloride extraction of plasma lipids followed by separation ofthe metabolites and purification from interfering contaminants by batch elution chromatography on Sephadex and Lipidex 5000 and by h.p.l.c. (high-pressure liquid chromatography). Vitamins D2 and D3 and 25(OH)D2 and 25(OH)D3 are quantified by h.p.l.c. by using u.v. detection, comparing their peak heights with those of standards. 24,25(OH)2D and 25,26(OH)2D are measured by competitive protein-binding assay with diluted plasma from vitamin D-deficient rats. 1,25(OH)2D is measured by competitive protein-binding assay with diluted cytosol from vitamin D-deficient chick intestine. Values in normal human plasma samples taken in February are: vitamin D 3.5 ± 2.5 ng/ml; 25(OH)D 31.6 ± 9.3 ng/ml; 24,25(OH)2D 3.5 ± 1.4ng/ml; 25,26(OH)2D 0.7 ± 0.5 ng/ml; 1,25(OH)2D 31 ± 9pg/ml (means ± S.D.). Values in two normal human plasma samples taken in February after 1 week of high sun exposure are: vitamin D 27.1 ± 7.9ng/ml; 25(OH)D 56.8 ± 4.2ng/ml; 24,25(OH)2D 4.3 ± 1.6 ng/ml; 25,26(OH)2D 0.5 ± 0.2 ng/ml. Values in anephric-human plasma are: vitamin D 2.7 ± 0.8ng/ml; 25(OH)D 36.4± 16.5ng/ml; 24,25(OH)2D 1.9± 1.3ng/ml; 25,26(OH)2D 0.6 ± 0.3 ng/ml; 1,25(OH)2D was undetectable.
It has been well established that vitamin D must be metabolized before its biological activity can be expressed. Vitamin D is hydroxylated to 25(OH)D in the liver (Blunt & DeLuca, 1969) and then further hydroxylated in the kidney to either 1,25(OH)2D or 24,25(OH)2D (DeLuca & Schnoes, 1976) . 1,25-(OH)2D is now recognized as the active form of vitamin D in bone -mineral mobilization and is exclusively responsible for the initiation of active intestinal absorption of calcium and phosphorus (DeLuca & Schnoes, 1976) . In contrast, a role for 24,25(OH)2D or 25,26(OH)2D [another known metabolite of 25(OH)D (Suda et al., 1970b) ] has yet to be Abbreviations used: vitamin D2, ergocalciferol; vitamin D3, cholecalciferol; 25(OH)D2, 25-hydroxyvitamin D2; 25(OH)D3, 25-hydroxyvitamin D3; 24,25-(OH)2D2, 24, 24, 25(OH) 2D3, 24, 25, 26(OH) 2D, 25,26-dihydroxyvitamin D; 1,25(OH)2D2, 1,25-dihydroxyvitamin D2; 1,25(OH)2D3, 1,25-dihydroxyvitamin D3; h.p.l.c., high-pressure liquid chromatography. established. The 25-hydroxylation reaction of vitamin D is partially feedback-regulated (Bhattacharyya & DeLuca, 1973) , whereas the metabolism of 25(OH)D to 1,25(OH)2D or 24,25(OH)2D is strictly modulated directly or indirectly by serum calcium, serum phosphorus and parathyroid hormone (DeLuca & Schnoes, 1976) . Further, the pathogenesis of several metabolic bone diseases is attended by disturbances in the vitamin D metabolicsystem (DeLuca & Schnoes, 1976) . In view of the above, a need developed for a multiple assay capable of measuring vitamin D and its metabolites in a single small sample of plasma.
Separate ligand-binding assays for the measurement of 25(OH)D (Belsey et al., 1971; Haddad & Chyu, 1971; Bayard et al., 1972; Edelstein et al., 1974; Preece et al., 1974; Bouillon et al., 1976; Garcia-Pascual et al., 1976) , 24,25(OH)2D (Haddad et al., 1976b (Haddad et al., , 1977 Taylor et al., 1976) , and 1,25-(OH)2D Eisman et al., 1976) in human plasma have been reported, but these are capable of measuring just one variable and many suffer from inadequate chromatography. Two metabolite assays have also been published Jones, 1978) , but these, too, are limited. (Lam et al., 1975 (Bhattacharyya & DeLuca, 1974) and purified on a column (1cm x 60cm) of Sephadex eluted with chloroform/hexane (1: 1, v/v) and a column (1cmrx660cm) of Lipidex 5000 eluted with hexane'chloroform (9:1, v/v (Yamada et al., 1978) ] by the method of Tanaka et al. (1978) . Both of these compounds were purified on a column (2cm x 40cm) of Sephadex LH-20 eluted with hexane/chloroform/methanol (9: 1: 1, by vol.) and then a column (1 cm x 60cm) of Sephadex v/v Tanaka et al. (1975) and purified on a column (1cm x 30cm) of Sephadex LH-20 eluted with chloroform/hexane (13:7, v/v) and then a column (2cmx40cm) of Sephadex LHW20 eluted with hexane/chloroform/methanol (9:1:1, by vol. (Suda et al., 1970a) to all standard and sample tubes, followed by 0.5 ml of diluted rat plasma (1:5000'dilution in 0.05M-sodium phosphate, pH7.4) on ice and the contents were vortex-mixed and incubated for at least 1 h or overnight at 4°C. In a 5 min period, 0.2 ml of cold 5 % charcoal/0.5 % dextran suspension in the same buffer was added to all tubes on ice, and their contents were vortex-mixed. After 30min on ice, the tubes were centrifuged at 4500rev./min for 20min at 4°C. Portions (0.5 ml) of the supernatant were mixed with 3.5ml of aqueous counting solution to determine protein-bound radioactivity. (Fig. 2b) . Standard curves of vitamins D2 and D3, relating peak heights corrected for recovery losses to ng applied, were virtually identical and linear (Fig. 3) . A typical h.p.l.c. profile of a normal human plasma sample (Fig. 4a) shows two peaks co-eluted with vitamin D2 and vitamin D3 standards, and the effective removal of all interfering 254nm-absorbing compounds from this region of the chromatogram. Also shown are h.p.l.c. profiles from anephric-human plasma and from plasma sampled immediately after the normal subject returned from 1 week of swimming in the Caribbean during midwinter (Figs. 4b and 4c) . 
Extraction ofplasma samples
Repetitive extractions with diethyl ether, methylene chloride or ethyl acetate alone yielded unsatisfactory recoveries for some of the tritiated metabolites of vitamin D added to plasma. Total lipid extraction, by the method of Bligh & Dyer (1959) , with the use of either chloroform or methylene chloride (Bouillon et al., 1976) , yielded superior recoveries of 90% or more after extraction of vitamin D, 25(OH)D, 24,25(OH)2D, 25,26(OH)2D and 1,25(OH)2D.
Initial chromatography oflipid extracts
The initial chromatographic step, batch elution from Sephadex LH-20 in hexane/chloroform/methanol (9: 1: 1, by vol.), removed the bulk of the interfering lipids from 25(OH)D and the dihydroxyvitamin D metabolites and separated the compounds into three fractions: the vitamin D fraction, the 25(OH)D fraction and the dihydroxyvitamin D fraction. A typical chromatogram illustrating the profile of the various vitamin D standards is shown in Fig. l(a) .
were observed in plasma from vitamin D-deficient chicks or rats.
Analysis of 25(OH)D2 and 25(OH)D3
Interfering u.v.-absorbing contaminants in the 25(OH)D-containing fraction eluted from Sephadex LH-20 were removed by batch elution on Lipidex 5000 eluted with hexane/chloroform (9: 1, v/v). 25(OH)D2 and 25(OH)D3 were slightly resolved by using this column (Fig. 1c ), but were collected together. They were completely resolved by h.p.l.c. on a Zorbax-SIL column eluted with propan-2-ol/ hexane (1:24, v/v) (Fig. 5) . Peak heights of the standards of 25(OH)D2 and 25(OH)D3, corrected for recovery losses, bore a linear relationship to the amount applied (Fig. 6 ). Since the 25(OH)D2-containing peak is slightly sharper than that containing 25(OH)D3 on the Zorbax-SIL column, the amount of 25(OH)D2 represented by a given peak height was only 760% of the amount of 25(OH)D3 represented ( as a standard. A typical Zorbax-SIL profile of a normal human plasma sample (Fig. 7a) (Jones & DeLuca, 1975 (Preece et al., 1974; Haddad et al., 1976a) , so it seems likely to be true for 24,25(OH)2D2 and 25,26(OH)2D2 as well.
After Sephadex LH-20 chromatography of the lipid extracts, the dihydroxyvitamin D fraction was chromatographed on two Zorbax-SIL columns in series eluted with propan-2-ol/hexane (13:87, v/v) at 2.Oml/min, and 1 ml fractions were collected and analysed by the rat-plasma-protein-binding assay. As shown in the binding profile in Fig. 10 (Fig. 10) shows the same four peaks, but there is considerably more peak I and less 24,25(OH)2D (peak III)-binding activity than in normal human plasma.
To determine whether peak I is related to vitamin D or is introduced by the solvents used, deionized water, vitamin D-deficient chick plasma and plasma from vitamin D3-repleted chicks and rats were extracted and their dihydroxyvitamin D fractions collected from the Sephadex LH-20 column and chromatographed on a single Zorbax-SIL column. As shown in Figs. 11(a) and 11(b), peak I binding activity is not observed in the water blank, but is observed in vitamin D-deficient chick plasma; peaks H, III and IV were not observed. [25, 26(OH) 2D3], as observed in human plasma. The peak I binding activity is much lower in vitamin D-repleted than in vitamin D-deficient chick plasma. Also present in both vitamin D-repleted chick and rat plasma is another peak (peak X) of binding activity, which is eluted immediately before 24,25(OH)2D3.
The analysis of 24,25(OH)2D in chick and rat plasma after h.p.l.c. on Zorbax-SIL would be interfered with by the presence of peak X. It was found, however, that reversed-phase h.p.l.c. on Partisil-ODS (Whatman column, 0.46cmx25cm) eluted with water/methanol (3:7, v/v) at 2.Oml/min is capable of completely resolving peak X and 24,25(OH)2D (Fig. 12) . Rechromatography of both the human 24,25(OH)2D-and 25,26(OH)2D-binding peaks from the Zorbax-SIL system by reversed-phase Partisil-ODS h.p.l.c. yielded single homogeneous binding peaks that were co-eluted with authentic 24,25(OH)2D3 and 25,26(OH)2D3, and confirmed that there is no interference with the assay of 24,25-(OH)2D and 25,26(OH)2D by peak X or other binding contaminants. 1,25(OH)2D was separated from 24,2 25,26(OH)2D and interfering binding con by h.p.l.c. as described above (Fig. 8) .
After Sephadex LH-20 chromatography of the lipid extracts, the dihydroxyvitamin D fraction was chromatographed on two Zorbax-SIL columns in series as described above, and 1 ml fractions were collected and analysed by the chick-intestinal-cytosolprotein-binding assay. The binding profile of normal human plasma (Fig. 14) , the intra-assay coefficients of variation were respectively 8 % (n = 5), 12 % (n = 6), 9 % (n = 6) and 17 % (n = 7), and the interassay coefficients of variation were 10 % (n= 8), 13 % (n = 3), 19 % (n = 3) and 26 % (n = 9). The Table 1 ) Total vitamin D determined by the h.p.l.c. procedure in plasma samples taken from a group of normal laboratory workers in February had a range of 0.9-7.2ng/ml (n = 8). Vitamin D2 in these samples was 0.5-4.6ng/ml, and vitamin D3 was 0.7-5.7ng/ml. Total 25(OH)D in normal samples ranged from 20.6 to 45.7 ng/ml (n = 19). 25(OH)D2 and 25(OH)D3 had respective ranges of 1.0-15.9ng/ml and 19.6-41.9ng/ml. The ranges of 24,25(OH)2D, 25,26-(OH)2D and 1,25(OH)2D respectively were 1.6-5.8 ng/ml (n = 12), 0.3-1.6ng/ml (n = 12) and 20-39pg/ml (n = 20). Vol. 182
Plasma samples taken from two normal subjects in February immediately upon returning from 1 week of swimming in the Caribbean were also analysed. The vitamin D2 concentrations were 1.5 and 0.5ng/ml, and vitamin D3 was 31.2 and 21.Ong/ ml. 25(OH)D2 was 1.6 and 1.Ong/ml, and 25(OH)D3 was 58.2 and 52.8ng/ml. Total 24,25(OH)2D was 3.2 and 5.4ng/ml, and total 25,26(OH)2D was 0.3 and 0.6 ng/ml.
Plasma samples from anephric patients were also subjected to the multiple assay. Total vitamin D had a range of 1.8-4.1 ng/ml (n = 6), with ranges of 0.7-2.4ng/ml and 0.5-1.9ng/ml for vitamin D2 and vitamin D3 respectively. Total 25(OH)D had a range of 18.6-75.9ng/ml (n = 9), with ranges of 2.2-34.4ng/ ml and 9.5-27.7ng/ml for 25(OH)D2 and 25(OH)D3 respectively. Total 24,25(OH)2D and 25,26(OH)2D had rangets of 0.5-4.2ng/ml (n = 9) and 0.5-1.3ng/ml (n = 9) respectively. There was no detectable 1,25-(OH)2D.
Discussion
The method outlined in this paper represents a new procedure for the quantification of vitamin D and its metabolites in a single small sample of human plasma. It is reasonably fast, accurate and reproducible. Before the vitamin D compounds can be analysed, the plasma lipid extract must be purified with separation ofthe metabolites to remove contaminants that interfere with measurement by h.p.l.c. using u.v. detection or by binding assay. Small-batch columns of Sephadex LH-20 (Holick & DeLuca, 1971) or Lipidex 5000 (Ellingboe et al., 1970) (Jones, 1978; Eisman et al., 1977; Haddad & Chyu, 1971; Preece et al., 1974) . These observations support the view that vitamin D is rapidly stored, with little circulating in the plasma (Ponchon & DeLuca, 1969) , whereas 25(OH)D is the major circulating form of vitamin D. The total vitamin D and 25(OH)D concentrations in anephric-human plasma were similar to our normal values, but the vitamin D2 analogue comprised a greater proportion of both compounds in anephric- (Lambert et al., 1977b ) is much higher than that reported by us or Jones (1978) and lower still than in their original abstract (Lambert et al., 1977a) . Also, their original normal value for 24,25(OH)2D (Lambert et al., 1977a) 
